In contrast, TNBC versus other tumor subtype was not more frequent among EA breast cancer cases with pathogenic variants in BRCA2 or PALB2 than among EA cases with no such variants (OR = 0.62 [0.18, 2.09]). This evidence concerns the gene PALB2 and breast carcinoma.